Market Place
Sourcing Support
STADA and Bio-Thera Secure EU Approval for Gotenfia
13 Feb 2026 //
PR NEWSWIRE
STADA & Bio-Thera`s Gotenfia Biosimilar Get Positive CHMP Opinion
12 Dec 2025 //
PR NEWSWIRE BIO
Bio-Thera Announces Expansion of Partnership with Intas Pharma
09 Oct 2025 //
PR NEWSWIRE
Bio-Thera`s Biosimilar Referencing Stelara Approved in the EU
26 Aug 2025 //
CONTRACTPHARMA
Bio-Thera, STADA Expand Biosimilars Alliance to Tocilizumab
23 Aug 2025 //
PR NEWSWIRE
FDA Accepts Bio-Thera`s BAT2506 Biosimilar License Application
16 Jul 2025 //
PR NEWSWIRE
Bio-Thera & SteinCares Expand Latin America Biosimilars Deal
25 Jun 2025 //
PR NEWSWIRE
Bio-Thera Doses First Patient in Ph3 for Ovarian ADC BAT8006
25 Jun 2025 //
PR NEWSWIRE
CHMP Recommends Bio-Thera’s Stelara Biosimilar Usymro
20 Jun 2025 //
PR NEWSWIRE
Bio-Thera and Hikma announce FDA approval of Starjemza Injection
27 May 2025 //
PR NEWSWIRE
Bio-Thera, Dr. Reddy`s sign exclusive deal for Stelara and Simpon
28 Mar 2025 //
PRESS RELEASE
Bio-Thera Signs Licensing Deal with Intas Pharma for BAT2506
10 Feb 2025 //
PR NEWSWIRE
Bio-Thera Solutions Announces EU Filing for BAT2506 Biosimilar
07 Feb 2025 //
PR NEWSWIRE
Bio-Thera with Tabuk to Commercialize Stelara in Saudi Arabia
26 Dec 2024 //
PRNEWSWIRE
Bio-Thera Expands LATAM Partnership with Third Biosimilar
16 Dec 2024 //
PR NEWSWIRE
Bio-Thera And Biogen Publish TOFIDENCE Phase 3 Trial Data
11 Sep 2024 //
PR NEWSWIRE
Bio-Thera`s Avastin Biosimilar Avzivi Gets Positive CHMP Opinion
03 Jun 2024 //
PR NEWSWIRE
Bio-Thera`s BAT8006 FR-alpha ADC Clinical Data At ASCO 2024
02 Jun 2024 //
PR NEWSWIRE
Bio-Thera, STADA: Golimumab Biosimilar EU, UK Agreement For BAT2506
28 May 2024 //
PR NEWSWIRE
BTS Receives IND Clearance From FDA to Initiate a Phase II Study for BAT8006
25 Mar 2024 //
PR NEWSWIRE
Bio-Thera Solutions Partners with SteinCares to Market Two Biosimilars in LATAM
18 Mar 2024 //
PR NEWSWIRE
Bio-Thera Announces Initiation of Phase IB / IIA Trial for BAT6026
01 Feb 2024 //
PR NEWSWIRE
FDA Approves Bio-Thera Solutions` Avzivi, a biosimilar referencing Avastin®
07 Dec 2023 //
PR NEWSWIRE
FDA Approves Bio-Thera’s Biosimilar of ACTEMRA
08 Oct 2023 //
PRESS RELEASE
FDA Approves TOFIDENCE™ (tocilizumab-bavi) a Biosimilar of ACTEMRA
08 Oct 2023 //
PR NEWSWIRE
Bio-Thera and Biomm enter licensing deal for ustekinumab biosimilar
19 Jun 2023 //
PHARMACEUTICAL TECHNOLOGY
Bio-Thera Expands Partnership with Biomm in Brazil with Addition of BAT2206
16 Jun 2023 //
BUSINESSWIRE
Bio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for BAT8007
13 Mar 2023 //
BUSINESSWIRE
Bio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for BAT8008
08 Mar 2023 //
BUSINESSWIRE
Bio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for BAT8010
06 Mar 2023 //
BUSINESSWIRE
China NMPA Approves Bio-Thera’s BAT1806, A Biosimilar to Actemra® (Tocilizumab)
16 Jan 2023 //
BUSINESSWIRE
